Table 5.
Number of samples detected correctly as related to the target gene for amplification
| Gene targeta | Number with positive tests/total number | ||||||
|---|---|---|---|---|---|---|---|
| Influenza A virus | MP (5) | NSP (5) | NP (3) | HA (1) | NA (1) | NK (2) | |
| Strong positive | 5 | 5 | 3 | 1 | 1 | 2 | 17/17 |
| Positive | 4 | 3 | 2 | 0 | 1 | 1 | 11/17 |
| Low positive | 4 | 2 | 2 | 0 | 1 | 1 | 10/17 |
| Influenza B virus | MP (4) | NSP (3) | NP (4) | HA (4) | – | NK (2) | |
| Strong positive | 4 | 3 | 4 | 4 | 2 | 17/17 | |
| Positive | 4 | 3 | 4 | 4 | 2 | 17/17 | |
| Low positive | 2 | 2 | 2 | 3 | 2 | 11/17 | |
| Parainfluenza virus 1 | HN (13) | NP (1) | – | – | – | NK (1) | |
| Strong positive | 11 | 1 | 1 | 13/15 | |||
| Positive | 8 | 0 | 1 | 9/15 | |||
| Low positive | 2 | 0 | 0 | 2/15 | |||
| Parainfluenza virus 3 | HN (9) | F (4) | NP (1) | – | – | NK (1) | |
| Strong positive | 9 | 3 | 1 | 1 | 14/15 | ||
| Positive | 7 | 0 | 0 | 1 | 8/15 | ||
| Low positive | 4 | 0 | 0 | 0 | 4/15 | ||
| Respiratory syncytial virus | F (6) | NP (7) | P (1) | NSP (1) | – | NK (1) | |
| Strong positive | 6 | 5 | 1 | 1 | 1 | 14/16 | |
| Positive | 5 | 4 | 1 | 0 | 1 | 11/16 | |
| Low positive | 5 | 2 | 1 | 0 | 1 | 9/16 | |
| Human metapneumovirus | F (3) | P (5) | NP (3) | 5′ NCR (1) | – | NK (2) | |
| Strong positive | 3 | 5 | 3 | 1 | 2 | 14/14 | |
| Positive | 2 | 5 | 3 | 1 | 2 | 13/14 | |
| Low positive | 2 | 5 | 2 | 1 | 2 | 12/14 | |
| Adenovirus | H (12) | MP (1) | – | – | – | NK (1) | |
| Strong positive | 11;10 | 1;1 | 1;1 | 13;12/14 | |||
| Positive | 9;6 | 1;1 | 1;1 | 12;8/14 | |||
| Low positive | 8;6 | 1;0 | 1;1 | 10;7/14 | |||
| Human rhinovirus | 5′ NCR (10) | NK (1) | |||||
| Strong positive | 10;7;10 | 1;1;1 | 11;8;11/11 | ||||
| Positive | 9;7;9 | 1;1;1 | 10;8;10/11 | ||||
| Low positive | 4;3;4 | 1;1;1 | 5;4;5/11 | ||||
| Human coronavirus 229E | NP (4) | P (2) | M (1) | – | NK (1) | ||
| Strong positive | 4 | 2 | 1 | 1 | 8/8 | ||
| Positive | 2 | 2 | 1 | 1 | 6/8 | ||
| Low positive | 1 | 1 | 1 | 1 | 4/8 | ||
| Human coronavirus OC43 | NP (4) | P (1) | M (1) | – | NK (1) | ||
| Strong positive | 4 | 1 | 1 | 1 | 7/7 | ||
| Positive | 3 | 1 | 1 | 1 | 6/7 | ||
| Low positive | 0 | 0 | 0 | 0 | 0/7 | ||
Abbreviations: MP, matrix protein gene; NSP, non-structural protein gene; NP, nucleoprotein gene; HA, hemagglutinin gene; NA, neuraminidase gene; HN, hemagglutinin-neuraminidase gene; 5′ NCR, 5′ non-coding region; F, fusion protein gene; P, polymerase gene; H, hexon gene; NK, not known. Numbers of laboratories using the individual targets are shown in parentheses.
Results of tests for adenoviruses 4 and 7 and rhinovirus types 16, 72 and 90, respectively, are shown, separated by semicolon.